Share on StockTwits
 

Equities research analysts at Northland Capital Partners increased their target price on shares of Spectranetics Corp. (NASDAQ:SPNC) to $20.00 in a research note issued to investors on Monday, ARN reports. The firm currently has an “under perform” rating on the stock. Northland Capital Partners’ target price would suggest a potential downside of 23.14% from the company’s current price.

Several other analysts have also recently commented on the stock. Analysts at Northland Securities downgraded shares of Spectranetics Corp. from a “market perform” rating to an “underperform” rating in a research note to investors on Monday. They now have a $20.00 price target on the stock. They noted that the move was a valuation call. Separately, analysts at Citigroup Inc. downgraded shares of Spectranetics Corp. from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday, January 7th. They now have a $26.00 price target on the stock, up previously from $21.00. Finally, analysts at Zacks upgraded shares of Spectranetics Corp. from a “neutral” rating to an “outperform” rating in a research note to investors on Monday, December 30th. They now have a $27.20 price target on the stock. Two analysts have rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the stock. Spectranetics Corp. presently has a consensus rating of “Hold” and a consensus price target of $24.19.

Shares of Spectranetics Corp. (NASDAQ:SPNC) traded down 3.92% on Monday, hitting $25.00. The stock had a trading volume of 492,640 shares. Spectranetics Corp. has a 52 week low of $15.52 and a 52 week high of $26.29. The stock’s 50-day moving average is $25.13 and its 200-day moving average is $20.34. The company’s market cap is $1.024 billion.

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.